Liver Carcinoma
Conditions
Keywords
Hepatocellular carcinoma, Radioablation
Brief summary
Number of shows: 20 patients Track: A month with three visiting Intervention: Nutritional assessment including anthropometry, bioelectrical impedance, biochemical tests, Psychometric Hepatic Encephalopathy Score and Critical Flicker Frequency.
Detailed description
There will be a prospective, longitudinal, comparative. It included 20 patients diagnosed with hepatocellular carcinoma. As there are a finite number of active patients at the institute, and no studies with sample size well established, has seen a sample size of 20 patients. The duration of individual monitoring shall be one month to three visits (baseline, week 2 and week 4 after receiving the first radiofrequency ablation). Each visit will be a nutritional assessment including anthropometry, bioelectrical impedance, biochemical tests, Psychometric Hepatic Encephalopathy Score (PHES) and Critical Flicker Frequency (CFF). Anthropometric measures to be taken are weight, height and arm circumference average. Bioelectrical impedance will be using a single frequency impedance meter (425 to -50 KHz, Range 0 to 10,000) Bioelectrical Body Composition Analyzer Quantium II RJL Systems. The team measured the subjects' impedance, resistance, reactance and phase angle by Lean Body program provided by the manufacturer. Hepatic encephalopathy be evaluated by testing PHES and was measured CFF, also also be measured ammonium, tumor necrosis factor, IL-1, IL-6, IL-10, renin angiotensin aldosterone.
Interventions
BEHAVIORALHCC under treatment with radioablation
The evaluation will take place over a period of 30 days.
Sponsors
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Patients with a diagnosis of hepatocellular carcinoma, treatment-naive and who are referred to the radiology department for radioablation as first therapy. * Outpatients. * Willingness to participate in the project.
Exclusion criteria
* Patients with hepato-renal diseases. * Patients diagnosed with hepatocellular carcinoma undergoing chemoembolization treatment, or who have received more than one session radioablation. * Patients with depression or psychiatric illnesses * Patients who do not agree to participate in the project.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Nutritional Status | Participants will be evaluated for a month | Measured with the following parameters:body weight and height (to calculate BMI), triceps skinfold and mid-arm circumference (to calculated mid-arm muscle circumference, fat mass, fat free mass total, intracellular and extracellular body water obtained by bioelectrical impedance analysis and individual vectors obtained by bioelectrical impedance vector analysis. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Minimal hepatic encephalopathy | Participants will be assessed for one month | Assessed by psychometric Hepatic Encephalopathy (PHES) and Critical Flicker Frequency (CFF) |
Countries
Mexico
Outcome results
None listed